Terms ending in 2040
Every in-force patent on Biogen Ma Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,660,054 | Medical Diagnostic and Treatment Systems and Their Methods of Use In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 11,814,362 | ASK1 Inhibiting Agents In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 11,793,974 | Fixation Devices for Catheters In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 11,820,760 | Crystalline Polymorphs of Bruton's Tyrosine Kinase Inhibitors In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 12,037,398 | ANTI-VLA-4 Antibodies Having Reduced Effector Function In force · High confidence | Biogen Ma Inc. | In force | High confidence | |
| US 12,453,718 | Drug for Treating or Preventing Cerebral Hemorrhage, and Method for Treating or Preventing Cerebral Hemorrhage Using the Drug In force · High confidence | Corxel Pharmaceuticals Hong Kong Limited | In force | High confidence | |
| US 12,486,289 | Tricyclic Compounds as Glycogen Synthase Kinase 3 (GSK3) Inhibitors and Uses Thereof In force · Medium confidence | Biogen Ma Inc. | In force | Medium confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
6 of these are in force and held by Biogen Ma Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.